Discontinuation report VAN-ALENDRONATE
| Report ID | 58332 |
| Drug Identification Number | 02428725 |
| Brand name | VAN-ALENDRONATE |
| Common or Proper name | ALENDRONIC ACID (ALENDRONATE SODIUM) |
| Company Name | VANC PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ALENDRONIC ACID |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2016-12-31 |
| Remaining supply date | 2016-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2639 VIKING WAY, UNIT 210 RICHMOND, BRITISH COLUMBIA CANADA V6V 3B7 |
| Company contact information | info@vancpharm.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2018-08-17 | French | Compare |
| v1 | 2018-08-17 | English | Compare |
Showing 1 to 2 of 2